Ercros Past Earnings Performance
Past criteria checks 1/6
Ercros has been growing earnings at an average annual rate of 12.5%, while the Chemicals industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 8.7% per year. Ercros's return on equity is 7.9%, and it has net margins of 4%.
Key information
12.5%
Earnings growth rate
13.8%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 8.7% |
| Return on equity | 7.9% |
| Net Margin | 4.0% |
| Next Earnings Update | 30 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Ercros makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 726 | 29 | 141 | 0 |
| 30 Sep 23 | 815 | 21 | 142 | 0 |
| 30 Jun 23 | 909 | 38 | 146 | 0 |
| 31 Mar 23 | 980 | 66 | 147 | 0 |
| 31 Dec 22 | 1,026 | 71 | 145 | 0 |
| 30 Sep 22 | 1,033 | 68 | 148 | 0 |
| 30 Jun 22 | 962 | 79 | 136 | 0 |
| 31 Mar 22 | 893 | 52 | 136 | 0 |
| 31 Dec 21 | 790 | 49 | 131 | 0 |
| 30 Sep 21 | 714 | 28 | 91 | 0 |
| 30 Jun 21 | 652 | 22 | 146 | 0 |
| 31 Mar 21 | 590 | 14 | 89 | 0 |
| 31 Dec 20 | 571 | 6 | 124 | 0 |
| 30 Sep 20 | 573 | 18 | 88 | 0 |
| 30 Jun 20 | 603 | 25 | 90 | 0 |
| 31 Mar 20 | 645 | 28 | 88 | 0 |
| 31 Dec 19 | 671 | 31 | 89 | 0 |
| 30 Sep 19 | 682 | 26 | 94 | 0 |
| 30 Jun 19 | 681 | 27 | 86 | 0 |
| 31 Mar 19 | 679 | 39 | 91 | 0 |
| 31 Dec 18 | 672 | 45 | 83 | 0 |
| 30 Sep 18 | 680 | 47 | 88 | 0 |
| 30 Jun 18 | 676 | 49 | 85 | 0 |
| 31 Mar 18 | 682 | 45 | 93 | 0 |
| 31 Dec 17 | 681 | 45 | 92 | 0 |
| 30 Sep 17 | 663 | 52 | 95 | 0 |
| 30 Jun 17 | 644 | 49 | 98 | 0 |
| 31 Mar 17 | 626 | 46 | 91 | 0 |
| 31 Dec 16 | 603 | 45 | 91 | 0 |
| 30 Sep 16 | 608 | 29 | 81 | 0 |
| 30 Jun 16 | 613 | 21 | 87 | 0 |
| 31 Mar 16 | 620 | 15 | 81 | 0 |
| 31 Dec 15 | 618 | 7 | 87 | 0 |
| 30 Sep 15 | 609 | -3 | 79 | 0 |
| 30 Jun 15 | 612 | -3 | 80 | 0 |
| 31 Mar 15 | 606 | -4 | 79 | 0 |
| 31 Dec 14 | 604 | -7 | 79 | 0 |
| 30 Sep 14 | 608 | 4 | 80 | 0 |
| 30 Jun 14 | 608 | 4 | 76 | 0 |
| 31 Mar 14 | 617 | 4 | 80 | 0 |
| 31 Dec 13 | 625 | 0 | 80 | 0 |
| 30 Sep 13 | 658 | -8 | 87 | 0 |
| 30 Jun 13 | 615 | -8 | 86 | 0 |
Quality Earnings: CRS1 has a large one-off gain of €3.5M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: CRS1's current net profit margins (4%) are lower than last year (6.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CRS1's earnings have grown by 12.5% per year over the past 5 years.
Accelerating Growth: CRS1's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CRS1 had negative earnings growth (-59.2%) over the past year, making it difficult to compare to the Chemicals industry average (-19.4%).
Return on Equity
High ROE: CRS1's Return on Equity (7.9%) is considered low.